Metalmark Capital

Orgenesis Acquires Control of Octomera with the Goal of Progressing its Decentralized Immuno-Oncology Portfolio to Clinic

Retrieved on: 
Wednesday, January 31, 2024

These factors highlight the need and are driving demand for our decentralized cell therapy approach.

Key Points: 
  • These factors highlight the need and are driving demand for our decentralized cell therapy approach.
  • In parallel to progressing our decentralized Octomera platform, the Company’s most advanced oncology therapeutic in development continues to make significant advances in terms of decentralized GMP production and proof of concept with respect to efficacy and safety.
  • We are very appreciative of Metalmark for supporting us through the biotech winter and seeing our decentralized vision for the future.
  • To learn more, please visit our website .

Alliance Technical Group Builds Nationwide Environmental Laboratory Network, Expanding Comprehensive Services

Retrieved on: 
Friday, November 17, 2023

DECATUR, Ala., Nov. 17, 2023 /PRNewswire/ -- Alliance Technical Group (Alliance) , a global leader in environmental compliance services, is pleased to announce the successful acquisitions of four environmental laboratories across the United States.

Key Points: 
  • DECATUR, Ala., Nov. 17, 2023 /PRNewswire/ -- Alliance Technical Group (Alliance) , a global leader in environmental compliance services, is pleased to announce the successful acquisitions of four environmental laboratories across the United States.
  • This marks the next milestone in Alliance's mission to provide comprehensive environmental solutions to its customer base.
  • Alliance Technical Group Builds Nationwide Environmental Laboratory Network, Expanding Comprehensive Services
    "The laboratory acquisitions are a significant adjacency for Alliance.
  • "It was also key to add technical capabilities and accreditations, such as PFAS and XRF, to better support Alliance's national leading environmental testing and monitoring services.

Macquarie Capital Principal Finance to Acquire Camin Cargo

Retrieved on: 
Wednesday, November 8, 2023

Macquarie Capital Principal Finance (Macquarie Capital) today announced that it has signed a definitive agreement to acquire Camin Cargo Control Holdings, Inc. (Camin Cargo), a global provider of independent testing, inspection and certification (TIC) services to the energy industry, from Metalmark Capital Partners, a middle-market private equity firm.

Key Points: 
  • Macquarie Capital Principal Finance (Macquarie Capital) today announced that it has signed a definitive agreement to acquire Camin Cargo Control Holdings, Inc. (Camin Cargo), a global provider of independent testing, inspection and certification (TIC) services to the energy industry, from Metalmark Capital Partners, a middle-market private equity firm.
  • “Camin Cargo plays a critical role in the downstream energy value chain, providing independent testing and inspection services that allow market participants to trade energy products with confidence and certainty,” said James Fincher, Managing Director at Macquarie Capital Principal Finance.
  • “Camin Cargo has been steadily growing market share in the Americas and Europe due to its outstanding reputation for accuracy, consistency and customer service.”
    Bill Eckmann, Head of Principal Finance, Americas at Macquarie Capital, added, “Given the global energy demand outlook, we see significant opportunity to accelerate Camin Cargo’s already-impressive growth, both organically and through acquisitions.
  • Kirkland & Ellis served as legal counsel and Strata Partners acted as financial advisor to Macquarie Capital Principal Finance.

Adam Love Named Chief Executive Officer of Allstar Services

Retrieved on: 
Thursday, October 19, 2023

Allstar Services announced today that its Board of Directors has appointed Adam Love as Chief Executive Officer.

Key Points: 
  • Allstar Services announced today that its Board of Directors has appointed Adam Love as Chief Executive Officer.
  • During his 20-year career, Adam has held multiple leadership roles in the residential and commercial services sectors, most recently as Chief Operating Officer at integrated facilities management solutions provider SMS Assist.
  • “I am thrilled to be joining the industry-leading team at Allstar, an organization that shares my strong focus on empowering employees, driving growth and delivering excellent service,” said Love.
  • “The Allstar team is a clear leader in the roofing and broader exterior home services market, with a history of successful growth and significant opportunities ahead.

NovoDynamics Welcomes Metalmark Capital Chairman and CEO Howard I. Hoffen to Board of Directors

Retrieved on: 
Wednesday, September 13, 2023

NovoDynamics , Inc., the artificial Intelligence (AI) solutions provider for the Dental Industry, this week announced that Howard I. Hoffen has joined its Board of Directors.

Key Points: 
  • NovoDynamics , Inc., the artificial Intelligence (AI) solutions provider for the Dental Industry, this week announced that Howard I. Hoffen has joined its Board of Directors.
  • Mr. Hoffen is the Chairman and CEO of Metalmark Capital, formerly Morgan Stanley Capital Partners, a growth equity investment firm focused primarily on privately held, middle market companies.
  • Mr. Hoffen joined Morgan Stanley in 1985 and was the Chairman and Chief Executive Officer of Morgan Stanley Capital Partners before forming Metalmark Capital Partners in 2004.
  • “NovoDynamics has a long track record of providing successful artificial intelligence solutions to governments and commercial enterprises, which differentiates it from others in the AI space,” said new NovoDynamics Director Howard Hoffen.

BOW RIVER CAPITAL EXPANDS PRIVATE EQUITY TEAM WITH TWO SENIOR HIRES

Retrieved on: 
Tuesday, August 15, 2023

Denver, Colo., Aug. 15, 2023 /PRNewswire/ -- Bow River Capital, a Denver-based alternative asset manager, has expanded its Private Equity team with two senior hires – Gaurav Sharma, Managing Director and Shayan Masoudpour, Director. They joined Bow River on August 10 and August 14, 2023, respectively, and bring more than 30 years of combined private equity experience at top-tier funds to Bow River Capital's Private Equity Team.

Key Points: 
  • Gaurav Sharma Joins as a Managing Director; Shayan Masoudpour Joins as a Director
    Denver, Colo., Aug. 15, 2023 /PRNewswire/ -- Bow River Capital, a Denver-based alternative asset manager, has expanded its Private Equity team with two senior hires – Gaurav Sharma, Managing Director and Shayan Masoudpour, Director.
  • They joined Bow River on August 10 and August 14, 2023, respectively, and bring more than 30 years of combined private equity experience at top-tier funds to Bow River Capital's Private Equity Team.
  • "We are thrilled to welcome Gaurav and Shayan to the team," said Greg Hiatrides, Managing Director and Head of Bow River Capital Private Equity.
  • Mr. Sharma has more than 18 years of investment experience and joins Bow River Capital from Investcorp International where he served most recently as Principal on the Private Equity Team with a focus on business and healthcare services.

Orgenesis Provides Business Update for Second Quarter of 2023

Retrieved on: 
Friday, August 11, 2023

GERMANTOWN, Md., Aug. 11, 2023 (GLOBE NEWSWIRE) -- Orgenesis Inc. (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies (CGT), today provided a business update for the second quarter ended June 30, 2023.

Key Points: 
  • (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies (CGT), today provided a business update for the second quarter ended June 30, 2023.
  • Vered Caplan, CEO of Orgenesis, said, “We are pleased to report revenue of approximately $7.0 million for the second quarter of 2023, which reflects the ongoing rollout of our POCare platform.
  • We recently rebranded the POC Services business from Morgenesis to Octomera, following an additional investment from MM OS Holdings, L.P. (“MM”), an affiliate of Metalmark Capital Partners (“Metalmark”), a leading private equity firm.
  • Overall, we believe we have built a scalable, high margin, recurring revenue business model.”
    The complete financial results for the second quarter of 2023 are available on the Company’s website in the Company’s Form 10-Q, which has been filed with the Securities and Exchange Commission.

Orgenesis Announces Name Change of Morgenesis Business Unit to Octomera

Retrieved on: 
Tuesday, July 11, 2023

Morgenesis was originally formed in 2022 to separate Orgenesis’ existing POCare Service and supply solutions from the other operations of Orgenesis.

Key Points: 
  • Morgenesis was originally formed in 2022 to separate Orgenesis’ existing POCare Service and supply solutions from the other operations of Orgenesis.
  • A new Octomera website and rebranding will be unveiled throughout the second half of 2023.
  • The capital from the MM investment is for the continued development of POCare Centers with a focus on expanding in the US market.
  • Octomera is focused on changing the paradigm of centralized cell and gene therapy (CGT) production to produce treatments in a decentralized point of care manner.

Claudia Zylberberg Appointed as Independent Board Member of POCare Business Subsidiary of Orgenesis

Retrieved on: 
Tuesday, May 30, 2023

GERMANTOWN, Md., May 30, 2023 (GLOBE NEWSWIRE) -- Orgenesis Inc .

Key Points: 
  • GERMANTOWN, Md., May 30, 2023 (GLOBE NEWSWIRE) -- Orgenesis Inc .
  • (NASDAQ: ORGS) (“Orgenesis” or the “Company”), a global biotech company working to unlock the full potential of cell and gene therapies (CGTs), today announced that cell and gene therapy pioneer Claudia Zylberberg, PhD has been appointed as an independent board member and senior advisor of its Morgenesis LLC (“Morgenesis”) point-of-care (POCare) subsidiary.
  • As founder, board member and former CEO of Akron Bio, Dr. Zylberberg has led Akron Bio to its leadership position among makers of cGMP-compliant ancillary materials, novel products, and tools for advanced and regenerative medicines.
  • “We’re very proud to have Claudia join us to guide Morgenesis as it redefines the possibilities for delivering POCare therapies,” said Vered Caplan, CEO of Orgenesis.

Orgenesis Secures an Additional $5 Million Investment from Metalmark Capital to Accelerate Growth of Point-of-Care Service Subsidiary

Retrieved on: 
Wednesday, May 10, 2023

This investment follows the previously announced investment of $30 million in November 2022.

Key Points: 
  • This investment follows the previously announced investment of $30 million in November 2022.
  • In addition, Metalmark has committed to investing up to an additional $15 million, subject to the achievement of certain milestones.
  • This additional investment will further propel our growth as we expand our global operations and add key personnel, enabling us to capitalize on the substantial demand for our POCare services.
  • Morgenesis will use the additional capital to support the development of additional POCare Centers, as well as the OMPULs in both the U.S. and international markets.